Signalling pathways in the molecular pathogenesis of ovarian granulosa cell tumours

被引:64
作者
Fuller, PJ [1 ]
Chu, S [1 ]
机构
[1] Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia
基金
英国医学研究理事会;
关键词
D O I
10.1016/j.tem.2004.02.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Granulosa cell tumours represent similar to5% of all malignant ovarian tumours. They exhibit many morphological, biochemical and hormonal features of proliferating normal preovulatory granulosa cells, including both estrogen and inhibin biosynthesis. The aetiology of these tumours remains unclear, although many recent studies and several animal models have focused on signalling pathways that are known to be important in the regulation of granulosa cell proliferation. Here, we discuss the information currently available about the possible molecular changes that might lead to neoplastic transformation in human granulosa cells. The identification of these changes might lead not only to improved diagnosis, management-and treatment of granulosa cell tumours, but could also offer new insights into normal granulosa cell biology.
引用
收藏
页码:122 / 128
页数:7
相关论文
共 71 条
[1]   Control of differentiation, transformation, and apoptosis in granulosa cells by oncogenes, oncoviruses, and tumor suppressor genes [J].
Amsterdam, A ;
Selvaraj, N .
ENDOCRINE REVIEWS, 1997, 18 (04) :435-461
[2]   Novel genes regulated by gonadotropins in granulosa cells: new perspectives on their physiological functions [J].
Amsterdam, A .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2003, 202 (1-2) :133-137
[3]   Evidence of a role for the INK4 family of cyclin-dependent kinase inhibitors in ovarian granulosa cell tumors [J].
Arcellana-Panlilio, MY ;
Egeler, RM ;
Ujack, E ;
Magliocco, A ;
Stuart, GCE ;
Robbins, SM ;
Coppes, MJ .
GENES CHROMOSOMES & CANCER, 2002, 35 (02) :176-181
[4]   The lutropin/choriocrctnadotropin receptor, a 2002 perspective [J].
Ascoli, M ;
Fanelli, F ;
Segaloff, DL .
ENDOCRINE REVIEWS, 2002, 23 (02) :141-174
[5]   MOLECULAR ALTERATIONS OF THE AKT2 ONCOGENE IN OVARIAN AND BREAST CARCINOMAS [J].
BELLACOSA, A ;
DEFEO, D ;
GODWIN, AK ;
BELL, DW ;
CHENG, JQ ;
ALTOMARE, DA ;
WAN, MH ;
DUBEAU, L ;
SCAMBIA, G ;
MASCIULLO, V ;
FERRANDINA, G ;
PANICI, PB ;
MANCUSO, S ;
NERI, G ;
TESTA, JR .
INTERNATIONAL JOURNAL OF CANCER, 1995, 64 (04) :280-285
[6]   Normal reproductive function in InhBP/p120-deficient mice [J].
Bernard, DJ ;
Burns, KH ;
Haupt, B ;
Matzuk, MM ;
Woodruff, TK .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (14) :4882-4891
[7]   PKB binding proteins: Getting in on the akt [J].
Brazil, DP ;
Park, J ;
Hemmings, BA .
CELL, 2002, 111 (03) :293-303
[8]   Estrogen actions in the ovary revisited [J].
Britt, KL ;
Findlay, JK .
JOURNAL OF ENDOCRINOLOGY, 2002, 175 (02) :269-276
[9]   The inhibins and ovarian cancer [J].
Burger, HG ;
Fuller, PJ ;
Chu, S ;
Mamers, P ;
Drummond, A ;
Susil, B ;
Neva, P ;
Robertson, DM .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2001, 180 (1-2) :145-148
[10]   Cyclin D2 and P27 are tissue-specific regulators of tumorigenesis in inhibin α knockout mice [J].
Burns, KH ;
Agno, JE ;
Sicinski, P ;
Matzuk, MM .
MOLECULAR ENDOCRINOLOGY, 2003, 17 (10) :2053-2069